A study has found that a large number of women diagnosed with breast cancer know little about the basic characteristics of the cancer:
A study has found that a large number of women diagnosed with breast cancer know little about the basic characteristics of the cancer:
The study was done by the Dana-Farber Cancer Institute in Boston and was published online on Jan. 26, 2015 by the journal Cancer. Read the abstract of “Racial/ethnic disparities in knowledge about one’s breast cancer characteristics.”
The researchers did phone interviews with 500 women in northern California who had been diagnosed with stage I to stage III breast cancer from 2010 to 2011:
The researchers asked the women questions about the characteristics of the cancer with which they had been diagnosed:
The results:
The researchers then compared the women’s answers to the information in their pathology reports:
Black and Hispanic women were less likely to answer the questions correctly than white women, even after the researchers took socioeconomic status and general health knowledge into account.
“We were really surprised by the results,” said Rachel Freedman, M.D., a medical oncologist at the Susan F. Smith Center for Women’s Cancers at Dana-Farber and the study’s first author.
The researchers believe this study is the first time women have been asked how much they know about the breast cancer they’ve been diagnosed with; Dr. Freedman proposed the study after seeing many women in her own practice who didn’t understand the reasons why they were receiving certain treatments.
"Our results illustrate the lack of understanding many patients have about their cancers and have identified a critical need for improved patient education and provider awareness of this issue," said Dr. Freedman. "Improving patients' understanding about why a particular treatment is important for her individual situation may lead to more informed decisions and better adherence to treatment."
A breast cancer diagnosis will include the information on the four key cancer characteristics:
Still, different labs report results in different ways and use technical terms that aren’t always reader-friendly. Plus, because some tests take longer to run than others and not all tests are done by the same lab, you get different test results at different times, which can be confusing. Patients may have questions for nurses or oncologists.
NCCN Updates Guidelines for Preferred Frontline Regimen for Advanced Nasopharyngeal Carcinoma
December 5th 2024The NCCN Guidelines Version 1.2025 for Cancer of the Nasopharynx listed toripalimab plus chemotherapy as the standalone preferred regimen in the frontline treatment of patients with advanced nasopharyngeal carcinoma.